Freestone Capital Holdings’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-158
Closed -$56K 297
2013
Q3
$56K Buy
+158
New +$90.5K 0.01% 349

Other funds holding ALT

Freestone Capital Holdings's ALT Position: Q4 2013 in Review

Freestone Capital Holdings sold out of Altimmune (ALT) in Q4 2013, closing a stake of 158 shares — an estimated $56K sold.

Freestone Capital Holdings first reported a position in ALT in Q3 2013 and held it in 1 quarter. The position peaked at $56K in Q3 2013. 37 funds tracked by Wall St. Rank hold ALT as of Q4 2013.

  • Freestone Capital Holdings reported no remaining Altimmune position as of Q4 2013 after selling out during the quarter.
  • Freestone Capital Holdings sold 158 Altimmune shares in Q4 2013, an estimated $56K.
  • Freestone Capital Holdings first reported a position in Altimmune in Q3 2013 and held it in 1 quarter.
  • Freestone Capital Holdings's Altimmune position peaked at $56K in Q3 2013.
  • 37 funds tracked by Wall St. Rank held Altimmune as of Q4 2013.

Based on Freestone Capital Holdings's 13F filing for Q4 2013, filed 13 Feb 2014.